ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2023 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2023 Earnings Call Transcript May 8, 2023

ACADIA Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.21.

Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to ACADIA Pharmaceuticals’ First Quarter 2023 Financial Results Conference Call. My name is Corey and I’ll be your coordinator for today. At this time, all participants are in a listen-only mode. We will be...